Clinical Manifestations of Peanut Allergy
Peanut allergies typically present with immediate-onset skin symptoms (urticaria, angioedema, erythema) in approximately 78-89% of cases, often accompanied by gastrointestinal symptoms (47%, especially vomiting), upper respiratory symptoms (42%), lower respiratory symptoms (32%), and less commonly cardiovascular involvement (6%) indicating anaphylaxis. 1, 2
Typical Presentation Pattern
The clinical picture follows a predictable organ involvement pattern:
- Skin manifestations are the most common initial presentation, occurring in nearly 90% of first reactions, including urticaria, erythema, and angioedema 1, 3
- Multi-organ involvement occurs in three-quarters of reactions, with symptoms rarely limited to a single organ system 2
- Gastrointestinal symptoms present in approximately half of cases, with vomiting being the most common manifestation (26-47%) 2, 3
- Respiratory symptoms affect 42% (upper) and 32% (lower respiratory tract), but rarely occur as the sole manifestation 2, 3
- Cardiovascular symptoms indicating anaphylaxis occur in approximately 6% of reactions 2
Critical Clinical Features
The severity of reactions is unpredictable and cannot be reliably predicted by previous reaction severity, specific IgE levels, or skin prick test wheal size. 1 This is a crucial pitfall—past mild reactions do not guarantee future mild reactions.
High-Risk Features for Severe Reactions:
- Coexistent asthma is the most consistently identified risk factor for severe or fatal reactions, particularly poorly controlled asthma 1, 4
- Previous severe reactions (though not predictive of future severity)
- Multiple food allergies
- Delayed or absent epinephrine administration
- Lack of skin symptoms during a reaction (paradoxically associated with more severe outcomes)
- Concomitant alcohol intake (increases allergen absorption) 1
Age-Specific Considerations
Peanut allergy most commonly presents in the first five years of life, with median age at diagnosis around 1.5 years 1, 4. More than 90% of peanut-allergic children have a history of eczema, asthma, rhinitis, or another food allergy 4. Importantly, 82% of peanut-allergic patients in referral clinics have atopic dermatitis, particularly those with severe dermatitis onset within the first 3 months of life 1.
Reaction Timing and Progression
Reactions are immediate-onset, IgE-mediated type 1 hypersensitivity responses characterized by:
- Rapid onset (typically within minutes)
- Smooth muscle contraction
- Mucous secretion
- Vasodilation
- Potential progression to systemic anaphylaxis 4, 5
Common Pitfall: Unpredictable Subsequent Reactions
Among patients with initial non-life-threatening reactions who experience subsequent exposures, 44% develop potentially life-threatening reactions during at least one of these subsequent exposures. 1 This underscores that initial reaction severity does not predict future severity—a critical counseling point for families.
Even more concerning, 71% of patients with initial life-threatening reactions experienced potentially life-threatening symptoms during subsequent reactions 1.
Eczema Exacerbation: A Rare Manifestation
While three-quarters of peanut-allergic patients have a history of eczema, eczema worsening occurs in only 10.5% of oral food challenges 2. This finding emphasizes that avoidance diets solely to control eczema are unnecessary and may actually hamper tolerance maintenance.
Dose-Response Relationship
Severe reactions can occur at any dose level, though the amount ingested is likely the major determinant of severity 1. The food form (cooked, raw, or processed) and co-ingestion of other foods also influence reaction severity 1.